Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Rajappa P, Eng KW, Bareja R, Bander ED, Yuan M, Dua A, et al. Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors. Neurooncol Adv. 2022;4(1):vdac031.

Kim J, Rustam S, Mosquera JM, Randell SH, Shaykhiev R, Rendeiro AF, et al. Unsupervised discovery of tissue architecture in multiplexed imaging. Nat Methods. 2022;19(12):1653-1661.

Dallimore CA, Quelle M, Désir LL, Sham S, Harshan M, Wahl SJ, et al. Calcifying Pseudoneoplasm of the Neuraxis in the Posterior Fossa: A Case Report and Literature Review. Cureus. 2022;14(1):e21562.

Bruehl FK, Kim AS, Li MM, Lindeman NI, Moncur JT, Souers RJ, et al. Tiered Somatic Variant Classification Adoption Has Increased Worldwide With Some Practice Differences Based on Location and Institutional Setting. Arch Pathol Lab Med. 2022;146(7):822-832.

Zhang T, Zhang G, Chen X, Chen Z, Tan AY, Lin A, et al. Low-dose carbon monoxide suppresses metastatic progression of disseminated cancer cells. Cancer Lett. 2022;546:215831.

Rodriguez-Flores JL, Messai-Badji R, Robay A, Temanni R, Syed N, Markovic M, et al. The QChip1 knowledgebase and microarray for precision medicine in Qatar. NPJ Genom Med. 2022;7(1):3.

Dias-Santagata D, Heist RS, Bard AZ, Da Silva AF, Dagogo-Jack I, Nardi V, et al. Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network. Oncologist. 2022;27(11):930-939.

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720-1748.

Berchuck JE, Baca SC, McClure HM, Korthauer K, Tsai HK, Nuzzo PV, et al. Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis. Clin Cancer Res. 2022;28(5):928-938.

Lakkaraja M, Scordo M, Mauguen A, Cho C, Devlin S, Ruiz JD, et al. Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6(3):1054-1063.